2003-2004 Grant Cycle : Research Grants Awarded
Biology of Breast Cancer
Understanding Telomere Dynamics in Breast Cancer
Steven Artandi, MD
Sripriya Rajaraman
Stanford University
$135,000
Using Mouse Models to Define the Pathway of P53-Mediated Tumor Suppression in Breast Cancer
Laura Attardi, PhD
Shashwati Basak
Stanford University
$135,000
INT6 is a Potential Breast Tumor Suppressor Gene that Regulates the Proteasome
Eric Chang, PhD
Jinfeng Suo
Baylor College of Medicine
$135,000
Role of Jun Activation Domain-Binding Protein (JAB1) in Breast Tumorigenesis
Francois Claret, PhD
Anita Korapati
The University of Texas MD Anderson Cancer Center
$135,000
Wrch1: A Novel Rho GTPase in Breast Cancer Development
Channing Der, PhD
Paul Campbell
University of North Carolina at Chapel Hill
$135,000
A Novel Strategy for the Identification of Tumor Suppressors in Human Breast Cancer
Stephen Elledge, PhD
Thomas Westbrook
Harvard Partners Center for Genetics and Genomics
$135,000
Regulation of PEA-15 During Breast Cancer Oncogenesis
Brunhilde Felding-Habermann, PhD
Joseph Krueger
The Scripps Research Institute
$135,000
The Role of BRCA1 in Development and Maintenance of Genomic Integrity in the Terminal End Bud
Priscilla Furth, MD
Shahin Assefnia
Georgetown University, Lombardi Cancer Center
$135,000
Characterization of Mcs7, an Inherited Mammary Carcinoma Susceptibility Locus on Rat Chromosome 10
Michael Gould, PhD
Michelle Cotroneo
University of Wisconsin-Madison
$135,000
Functional and Structural Interactions Between Rad51, Rad54, and Brca2 Proteins During Recombinational DNA Repair of DNA Double-Stranded Breaks
Wolf-Dietrich Heyer, PhD
Xiao-Ping Zhang
University of California, Davis
$135,000
Molecular Mechanisms of Fas-Mediated Cell Death Induced by Tumor-Specific Ether Lysophospholipid Derivatives.
Anne-Odile Hueber, PhD
Krittalak Chakrabandhu
Institute of Signaling, Developmental Biology, and Cancer
$135,000
Molecular Mechanisms of LRH-1 Function in Breast Tissue
Holly Ingraham, PhD
Miyuki Suzawa
University of California, San Francisco
$135,000
DNA Methylation of SLIT-2 as a New Marker for the Early Diagnosis and the Use of Soluble
SLIT-2 as a New Therapeutic for Breast Cancer
John Minna, MD
Catherine Morrissey
UT Southwestern Medical Center
$135,000
The Proteome of Delta Protein Kinase C in Breast Cancer
Daria Mochly-Rosen, PhD
Tomoyoshi Koyanagi
Stanford University School of Medicine
$135,000
Role of Gab2 in Breast Cancer
Benjamin Neel, PhD
Richard Chan
Beth Israel Deaconess Medical Center, Harvard Medical School
$135,000
E2F Transcription Factors in Mammary Gland Development and Tumorigenesis
Joseph Nevins, PhD
Eran Andrechek
Duke University
$135,000
Regulation of Genomic Stability Through Cell Cycle Checkpoint Signaling
Matthew O'Connell, PhD
Ana Kosoy
Mount Sinai School of Medicine
$135,000
Defining the Role of a Novel CDK-Related Kinase in Cell Cycle Progression
Patrick O'Farrell, PhD
Gilles Hickson
University of California, San Francisco
$135,000
Centrosome Replication and the Role of BRCA1 in Breast Cancer
Jeffrey Parvin, MD
Satish Sankaran
Brigham and Women's Hospital
$135,000
THE ROLE OF CXCL12 AND CXCL14 CHEMOKINES IN THE REGULATION OF BREAST CANCER CELL GROWTH AND INVASION
Kornelia Polyak, MD
Kandilci Ayten
Dana-Farber Cancer Institute
$135,000
The Role of CKS Proteins in Cell Cycle Control and Breast Cancer
Steven Reed, PhD
Li-Chiou Chuang
The Scripps Research Institute
$135,000
Mechanism for BRCA1 Regulation of Genomic Stability
Eliot Rosen, MD
Jeong Rih
Georgetown University
$135,000
Role of Novel Sulfatases in Breast Cancer
Steven Rosen, PhD
Roman Nawroth
University of California San Francisco
$135,000
Characterization and Targeting of Cell Surface Expressed Nucleolin in Breast Cancer Angiogenesis
Erkki Ruoslahti, MD
Valentina Fogal
The Burnham Institute
$135,000
Functional Significance of HtrA1 Downregulation in Breast Cancer: Implications for Platinum Resistance
Viji Shridhar, PhD
Jonathan Baines
The Mayo Clinic/Foundation
$135,000
The Role of Estrogen Receptor Coactivators in Tamoxifen Resistance
Carolyn Smith, PhD
Eleni Maniatis
Baylor College of Medicine
$135,000
Functional Roles of HOXB7 in Tumorigenesis and Metastasis of Mammary Carcinoma
Saraswati Sukumar, PhD
TAO ZHU
Johns Hopkins University School of Medicine
$135,000
Riboflavin Trafficking in Breast Cancer
Peter Swaan, PhD
Alan Myers
University of Maryland
$135,000
The Role of TP53 Mutation in Genome Stability and Chemotherapeutic Resistance in Breast Cancer
Barbara Weber, MD
Mackenzie De Vos
University of Pennsylvania
$135,000
Vitamin D3 and Wnt/B-catenin Signaling in Mammary Cells
JoEllen Welsh, PhD
Matthew Rowling
University of Notre Dame
$135,000
Characterization of the Tumor Suppresssor RASSF1A in Breast Cancer Initiation and Progression
Michael White, PhD
Yu-Chen Chien
University of Texas Southwestern Medical Center at Dallas
$134,703
Early Detections, Diagnosis, and Prognosis
ErbB receptors and resistance to aromatase inhibitors in breast cancer
Carlos Arteaga, MD
Tracy Criswell
Vanderbilt University Medical Center
$135,000
Measurement of the X-Ray Attenuation Coefficients of Breast Tissues and Tumors Using Digital Tomosynthesis
Daniel Kopans, MD
Tao Wu
Massachusetts General Hospital
$135,000
Etiology
Molecular Epidemiology of Secondary Lung Cancer in Breast Cancer Patients
Peter Shields, MD
Funda Orkunoglu-Suer
Georgetown University
$135,000
Treatment
Mechanisms of Responses of Cancer Cells to Mutant-Template Telomerase RNA.
Elizabeth Blackburn, PhD
Claire Warner
The Regents of the University of California
$135,000
Use of Hypoxia- and Radiation-activated Cre/loxP Switch Vectors for Gene Therapy of Breast Cancer
Michael Joiner, PhD
Olga Greco
Wayne State University
$135,000
Mechanistic Synergy of HDAC and Topo II Inhibitors
Pamela Munster, MD
Douglas Marchion
H. Lee Moffitt Cancer Center and Research Institute
$135,000
NB2 a Novel Antitumor Agent for Breast Cancer: Implication of Proteomics in Target Identification
Nouri Neamati, PhD
Jinxia (Nancy) Deng
University of Southern California
$135,000
The Role of Growth Factors/Stress Signaling Pathways in Developing Endocrine Resistance of Breast Cancer
Kent Osborne, MD
Grazia Arpino
Breast Center, Baylor College of Medicine
$135,000
Structure-Based Inhibitor Design for a Cancer Target in De Novo Purine Biosynthesis Pathway
Ian Wilson, PhD
Stephen Connelly
The Scripps Research Institute
$135,000
* Pending executed agreement
